Acidosis Acts through HSP90 in a PHD/VHL-Independent Manner to Promote HIF Function and Stem Cell Maintenance in Glioma

被引:80
作者
Filatova, Alina [1 ]
Seidel, Sascha [1 ,2 ,3 ]
Boeguercue, Nuray [1 ]
Graef, Sabine [1 ]
Garvalov, Boyan K. [1 ]
Acker, Till [1 ]
机构
[1] Univ Giessen, Inst Neuropathol, Arndtstr 16, D-35392 Giessen, Germany
[2] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany
[3] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany
关键词
HYPOXIA-INDUCIBLE FACTORS; CARBONIC-ANHYDRASE IX; P-GLYCOPROTEIN; MELANOMA-CELLS; UP-REGULATION; IN-VIVO; GROWTH; EXPRESSION; PROTEIN; TUMORS;
D O I
10.1158/0008-5472.CAN-15-2630
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Hypoxia is a common feature of solid tumors, which controls multiple aspects of cancer progression. One important function of hypoxia and the hypoxia-inducible factors (HIF) is the maintenance of cancer stem-like cells (CSC), a population of tumor cells that possess stem cell-like properties and drives tumor growth. Among the changes promoted by hypoxia is a metabolic shift resulting in acidification of the tumor microenvironment. Here, we show that glioma hypoxia and acidosis functionally cooperate in inducing HIF transcription factors and CSC maintenance. We found that these effects did not involve the classical PHD/ VHL pathway for HIF upregulation, but instead involved the stress-induced chaperone protein HSP90. Genetic or pharmacologic inactivation of HSP90 inhibited the increase in HIF levels and abolished the self-renewal and tumorigenic properties of CSCs induced by acidosis. In clinical specimens of glioma, HSP90 was upregulated in the hypoxic niche and was correlated with a CSC phenotype. Our findings highlight the role of tumor acidification within the hypoxic niche in the regulation of HIF and CSC function through HSP90, with implications for therapeutic strategies to target CSC in gliomas and other hypoxic tumors. (C) 2016 AACR.
引用
收藏
页码:5845 / 5856
页数:12
相关论文
共 50 条
[1]
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases [J].
Becker, B ;
Multhoff, G ;
Farkas, B ;
Wild, PJ ;
Landthaler, M ;
Stolz, W ;
Vogt, T .
EXPERIMENTAL DERMATOLOGY, 2004, 13 (01) :27-32
[2]
A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[3]
Expression and Regulation of AC133 and CD133 in Glioblastoma [J].
Campos, Benito ;
Zeng, Lingcheng ;
Daotrong, Philip H. ;
Eckstein, Volker ;
Unterberg, Andreas ;
Mairbaeurl, Heimo ;
Herold-Mende, Christel .
GLIA, 2011, 59 (12) :1974-1986
[4]
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer [J].
Cheng, Qing ;
Chang, Jeffrey T. ;
Geradts, Joseph ;
Neckers, Leonard M. ;
Haystead, Timothy ;
Spector, Neil L. ;
Lyerly, H. Kim .
BREAST CANCER RESEARCH, 2012, 14 (02)
[5]
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer [J].
Chiche, Johanna ;
Brahimi-Horn, M. Christiane ;
Pouyssegur, Jacques .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (04) :771-794
[6]
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH [J].
Chiche, Johanna ;
Ilc, Karine ;
Laferriere, Julie ;
Trottier, Eric ;
Dayan, Frederic ;
Mazure, Nathalie M. ;
Brahimi-Horn, M. Christiane ;
Pouyssegur, Jacques .
CANCER RESEARCH, 2009, 69 (01) :358-368
[7]
Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068
[8]
Damert A, 1997, CANCER RES, V57, P3860
[9]
Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models [J].
Di, Kaijun ;
Keir, Stephen T. ;
Alexandru-Abrams, Daniela ;
Gong, Xing ;
Nguyen, Howard ;
Friedman, Henry S. ;
Bota, Daniela A. .
JOURNAL OF NEURO-ONCOLOGY, 2014, 120 (03) :473-481
[10]
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation [J].
Epstein, ACR ;
Gleadle, JM ;
McNeill, LA ;
Hewitson, KS ;
O'Rourke, J ;
Mole, DR ;
Mukherji, M ;
Metzen, E ;
Wilson, MI ;
Dhanda, A ;
Tian, YM ;
Masson, N ;
Hamilton, DL ;
Jaakkola, P ;
Barstead, R ;
Hodgkin, J ;
Maxwell, PH ;
Pugh, CW ;
Schofield, CJ ;
Ratcliffe, PJ .
CELL, 2001, 107 (01) :43-54